Yongyi Yuan, Hao Guo, Siming Zheng, Keshu Zhou. "Targeting SF3B1 disrupts CLL cell survival via pfkfb-mediated glycolytic dependency and confers vulnerability to BTK inhibition." Blood, 2025. doi:10.1182/blood-2025-7409